Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 21, 2014

View Archived Issues

Novel compounds target the FtsZ protein in M. tuberculosis

Genome-wide screening for rare genetic variants associated with RLS

In vivo results reveal potent antitumor activity for the novel pan-Notch inhibitor BMS-986115

LC-MS/MS assay can detect vitamin B12 deficiency

Immune Targeting Systems partners its H1N1 influenza challenge virus

Alcobra enrolls first patient in phase IIb study of metadoxine in fragile X syndrome

Mitsubishi Tanabe Pharma and AstraZeneca form diabetic nephropathy collaboration

Garvan and Roche Sequencing to collaborate on targeted epigenomic analysis using DNA sequencing

Sinocelltech to conduct phase I study of anti-EGFR antibody in patients with colorectal cancer

Nogo-A, a valid target for ALS therapy

Emergent BioSolutions and MorphoSys to co-develop bispecific protein for prostate cancer

Eisai files for U.S. and E.U. approval of perampanel for primary generalized tonic-clonic seizures

Novel pyridones inhibit T790M double mutant EGFR

Novartis provides candidate compounds to Global Alliance for TB Drug Development

Isis Pharmaceuticals to begin phase III trial in familial chylomicronemia syndrome

Bayer Schering Pharma patents new Mnk1 inhibitors

Chinese researchers divulge novel DHODH inhibitors

Gruenenthal patents new PDE4B inhibitors

New mGlu4 receptor PAMs described by Merck KGaA

CSL Behring's Hizentra obtains orphan drug status for CIDP

NovaBay reports phase II data for NVC-422 in viral conjunctivitis

NCI launches nationwide trial to assess targeted drugs in early-stage lung cancer

U.S. rights For Treximet acquired by Pernix Therapeutics

Stemedica's stem cell therapy reduces Abeta plaques in Alzheimer's disease model

Fluticasone furoate inhalation powder approved in the US for asthma

Marketing approval granted for KRONUS ZnT8Ab ELISA Assay for diagnosis of type 1 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...